EC5026   Click here for help

GtoPdb Ligand ID: 12750

Synonyms: BPN-19186 | BPN19186 | EC-5026
Compound class: Synthetic organic
Comment: EC5026 is a first-in-class, orally active soluble epoxide hydrolase (sEH; epoxide hydrolase 2; EPHX2) inhibitor [1]. It was designed fo treat inflammatory and neuropathic pain.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 70.67
Molecular weight 405.39
XLogP 2.94
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@H](C)C(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C(=C2)F)OC(F)(F)F
Isomeric SMILES O=C(NC1=CC(F)=C(C=C1)OC(F)(F)F)NC2CCN(C([C@H](CC)C)=O)CC2
InChI InChI=1S/C18H23F4N3O3/c1-3-11(2)16(26)25-8-6-12(7-9-25)23-17(27)24-13-4-5-15(14(19)10-13)28-18(20,21)22/h4-5,10-12H,3,6-9H2,1-2H3,(H2,23,24,27)/t11-/m0/s1
InChI Key LHRXHTKENPCGSZ-NSHDSACASA-N
Bioactivity Comments
EC5026-mediated inhibition of sEH prevents its degradation of epoxides of polyunsaturated fatty acids (EpFA) which are endogenous mediators that help resolve inflammation and produce analgesic effects.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
epoxide hydrolase 2 Hs Inhibitor Inhibition >10.3 pKi - 1
pKi >10.3 (Ki <5x10-11 M) [1]